Literature DB >> 19333527

[Transitions in drug abuse in Colombia].

Augusto Pérez Gómez1.   

Abstract

Transitions in drug abuse (going from one substance to another and from one form of administration to another) has been scarcely studied in Latin America. In this project 96 people in treatment, aged 14 to 50, were interviewed in seven Colombian cities. Five kinds of transition were identified: general, cumulative, substitutive, reverse and negative, occurring at nine different points; 113 transitional patterns (combinations of two substances) were found, 23 common to men and women, 10 exclusive to women and 80 exclusive to men. Contrary to all expectations, 21 cases of heroin users appeared in this sample, mainly among upper- and middle-class users, more in men than in women, and in very young people: 11 out of 21 were under 20 years of age. The 10 main transitions only involve four substances: marihuana, cocaine, inhalants and tranquillizers, and are most common amongst those under age 23. The youngest use marihuana, cocaine, tranquillizers, glues, ecstasy, poppers and heroin; the eldest prefer cocaine, basuco and marihuana. Mixtures, changes of substance and changes of from of administration are always associated with a search for more powerful effects. Many youngsters believe that marihuana is either harmless or beneficial, because it can cure cancer caused by smoking tobacco. Heroin is considered the most dangerous drug because of its bad effects on all levels. The main limitations of this study were: the small number of participants, the even smaller number of women, and the fact that only people in treatment were interviewed.

Entities:  

Mesh:

Year:  2009        PMID: 19333527

Source DB:  PubMed          Journal:  Adicciones        ISSN: 0214-4840            Impact factor:   2.979


  1 in total

1.  Problems associated with alcohol consumption by university students.

Authors:  Guillermo Alonso Castaño-Perez; Gustavo Adolfo Calderon-Vallejo
Journal:  Rev Lat Am Enfermagem       Date:  2014-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.